Bardet-Biedl Syndrome Clinical Trial
Official title:
COhort for Bardet-Bield Syndrome and Alström Syndrome for Translational Research Etude Interventionnelle Monocentrique
ALMS and BBS syndromes are rare diseases with overlapping features of multiple sensory and metabolic impairments, including diabetes mellitus. There are to date no specific treatments available and limited information on the natural history of the diseases. the investigators aim to establish a French cohort for these diseases to improve patient care and assess the effect of actual therapies on quality of life. The purpose of this study is to establish a cohort of Bardet-Bield syndrome (BBS) and ALström syndrome (ALMS) patients in order to formalize and address questions concerning the in-depth natural clinical and biological history of the disease on the long term for a given patient, establish the impact on the quality of life of various clinical manifestations
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04874909 -
Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM)
|
N/A | |
Recruiting |
NCT02435940 -
Inherited Retinal Degenerative Disease Registry
|
||
Recruiting |
NCT02329210 -
Clinical Registry Investigating Bardet-Biedl Syndrome
|
||
Completed |
NCT00213811 -
Bardet-Biedl Syndrome Study: Clinical and Genetic Epidemiology Study in Adults
|
N/A | |
Recruiting |
NCT06239064 -
Early Genetic Identification of Obesity
|
||
Terminated |
NCT00078091 -
Genetics and Clinical Characteristics of Bardet-Biedl Syndrome
|
||
Completed |
NCT04966741 -
Setmelanotide in Pediatric Patients With Rare Genetic Diseases of Obesity
|
Phase 3 | |
Enrolling by invitation |
NCT05400278 -
Characterizing the Genotype and Phenotype in Adults With Bardet-Biedl Syndrome
|
||
Completed |
NCT05194124 -
Phase 3 Crossover Trial of Two Formulations of Setmelanotide in Patients With Specific Gene Defects in the MC4R Pathway
|
Phase 3 | |
Withdrawn |
NCT03490019 -
Treatment of Bardet-Biedl-Syndrome With Metformin for Evaluation of a Possible Visual Improvement
|
Phase 2 |